Antioxidants in the prevention of cardiovascular disease;Papel de los antioxidantes en la prevención de la enfermedad cardiovascular

Medicina Clinica

Volumn 116, Issue 16, 2001, Pages 629-635

  Paramo J A ^a   Orbe, J ^a   Rodriguez J A ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

Antioxidants; Atherosclerosis; PAI I; Vitamin C; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CAROTENOID;

CARDIOVASCULAR DISEASE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE COURSE; DRUG MECHANISM; HUMAN; OXIDATION; REVIEW;

EID: 0035810524     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71926-4     Document Type: Review

References (83)

1. Atherosclerosis. An inflammatory disease
2. Atherosclerosis
3. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocyte/macrophages during atherogenesis
4. Beyond cholesterol: Modifications of low-density lipoprotein cholesterol that increase its atherogenicity
5. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
6. Low density lipoprotein oxidation and its pathobiological significance
7. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress
8. Hypercholesterolemia increases endothelial superoxide anion production
9. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone
10. Free radicals mediate endothelial cell dysfunction caused by elevated glucose
11. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells
12. Antioxidants inhibit the expression of intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 induced by oxidized LDL on human umbilical vein endothelial cells
13. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice
14. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
15. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
16. Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells
17. Tissue factor pathway inhibitor is expressed by human monocyte-derived macrophages: Relationship to tissue factor induction by cholesterol and oxidized LDL
18. Oxidized LDL and lysophosphatidilcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells
19. Papel del PAl-1 en los procesos trombóticos
20. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase
21. Biodiscrimination of alpha-tocopherol stereoisomers in humans after oral administration
22. Absorption, transport and distribution of vitamin E
23. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms
24. Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation
25. Alpha-tocoferol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity
26. Vitamin E deficiency and neurologic disease
27. Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations
28. Glutathione-ascorbic acid antioxidant system in animals
29. L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells
30. Antioxidants and atherosclerotic heart disease
31. Reversibilidad de la función endotelial y cambios hemostaticos en la prevención y tratamiento de la aterosderosis
32. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and α-tocoferol (vitamin E)
33. Dietary antioxidants for cardiovascular prevention
34. Requirement for promotion or inhibition by α-tocoferol of radical-induced initiation of plasma lipoprotein lipid peroxidation
35. Vitamin C protects against and reverses specific hypochlorus acid and chloramine-dependent modification of low-density-lipoprotein
36. The antioxidant paradox
37. Low-dose alpha-tocopherol improves and high-dose alpha-to-copherol worsens endothelial vasodilator function in cholesterol-fed rabbits
38. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women
39. Effects of vitamin E on susceptibility of low-density lipoprotein and low-density lipoprotein subfractions to oxidation and on protein glycation in NIDDM
40. Effect of ascorbate supplementation on low-density lipoprotein oxidation in smokers
41. L-ascorbic acid potentiates nitric oxide synthesis in endothelial cells
42. Antioxidants and the bioactivity of endothelium-derived nitric oxide
43. Vitamin C improves endothelial-dependent vasodilatation in patients with non-insulin dependent diabetes mellitus
44. Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients
45. Vitamin E administration improves impairment of endothelium dependent vasodilatation in patients with coronary spastic angina
46. Effect of vitamin E on endothelial vasodilatator function in patients with hypercholesterolemia, chronic smoking or both
47. Effect of copper-zinc superoxide dismutase on endothelium dependent vasodilatation in patients with essential hypertension
48. Dietary antioxidants preserve endothelium dependent vessel relaxation in cholesterol-fed rabbits
49. Vascular incorporation of alpha-to-coferol prevents endothelial dysfunction due to oxidized LDL by inhibiting protein kinase C stimulation
50. Antioxidants inhibit the expression of intercellular adhesion mollecule-1 and vascular cell adhesion mollecule-1 induced by oxidized LDL on human umbilical vein endothelial cells
51. Vitamin E inhibits low-density-lipoprotein-induced adhesion of monocytes to human aortic endothelial cells in vitro
52. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty: Multivitamins and Probucol Study Group
53. α-Tocoferol inhibits aggregation of human ptatelets by a protein kinase C-dependent mechanism
54. Vitamin E and vascular homeostasis: Implications for atherosclerosis
55. Vitamins C and E attenuate plasminogen activator inhibitor-1 (PAI-1) expression in a hypercholesterolemic porcine model of angioplasty
56. Antioxidant consumption and risk of coronary heart disease: Emphasis on vitamin C, vitamin E, and β-carotene
57. Vitamin E consumption and the risk of coronary heart disease in women
58. Vitamin E consumption and the risk of coronary heart disease in men
59. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly
60. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women
61. Provitamin A carotenoid intake and carotid artery plaques: The Atherosclerosis Risk in Communities Study
62. Vitamin C intake and mortality among a sample of the United States population
63. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women
64. Multivitamin use and mortality in a large prospective study
65. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers
66. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E, after myocardial infarction: Results of the GISSI-Prevenzione Trial
67. Vitamin E supplementation and cardiovascular events in high-risk patients
68. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
69. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
70. The antioxidant vitamins and cardiovascular disease: A critical review of epidemiologic and clinical trial data
71. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population
72. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study
73. Randomized trial of α-tocoferol and α-carotene supplements on the incidence of major coronary events in men with previous myocardial infarction
74. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis
75. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering
76. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
77. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3)
78. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA)
79. Possible prevention of postangioplasty restenosis by ascorbic acid
80. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty. The Probucol Angioplasty Restenosis Trial
81. Antioxidants for vascular disease
82. ¿Se deben recomendar antioxidantes para la prevención cardiovascular?
83. AHA dietary guidelines. Revision 2000: A statement for health professionals from the Nutrition Committee of the American Heart Association